Ligand validation:6DO1

OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate

OLC is a Ligand Of Interest in 6DO1 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6DO1_OLC_B_1006	22%	43%	0.199	0.892	1.21	1.03	1	1	0	0	56%	0.56
6DO1_OLC_B_1004	20%	2%	0.217	0.865	1.17	6.15	1	4	0	0	76%	0.76
6DO1_OLC_A_1005	11%	44%	0.295	0.875	1.13	1.08	1	1	0	0	68%	0.68
6DO1_OLC_B_1005	11%	78%	0.234	0.825	0.21	0.67	-	-	0	0	56%	0.56
6DO1_OLC_A_1006	8%	34%	0.262	0.822	1.4	1.3	1	1	4	0	52%	0.52
6OS2_OLC_A_1406	14%	45%	0.206	0.844	1.09	1.06	2	1	0	0	52%	0.52
6OS1_OLC_A_1405	12%	45%	0.21	0.827	1.09	1.05	2	1	0	0	52%	0.52
7Z0C_OLC_A_803	63%	52%	0.097	0.892	0.82	1.04	1	2	2	0	100%	1
4N6H_OLC_A_1222	62%	56%	0.117	0.932	0.81	0.87	1	1	0	0	88%	0.88
5IU4_OLC_A_2429	61%	58%	0.136	0.926	0.8	0.78	2	1	1	0	100%	1
6G7H_OLC_A_310	61%	92%	0.117	0.905	0.26	0.26	-	-	0	0	100%	1
7B0O_OLC_A_302	59%	55%	0.146	0.929	0.68	1.06	1	1	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.